New Findings from S. Thonnes and Co-Authors in the Area of Chronic Hepatitis C Virus Reported (The number of patients with chronic hepatitis C in…

New Findings from S. Thonnes and Co-Authors in the Area of Chronic Hepatitis C Virus Reported (The number of patients with chronic hepatitis C in times of new therapy options: a retrospective observational study on German health insurance funds ...)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Investigators publish new report on Liver Diseases and Conditions - Chronic Hepatitis C Virus. According to news reporting originating from Wiesbaden, Germany, by VerticalNews correspondents, research stated, "Chronic hepatitis C (CHC) virus infection is a leading cause of liver-related morbidity and mortality. In Germany, as in many other countries, there is a lack of comprehensive epidemiological data."

Our news editors obtained a quote from the research, "Routine data from sickness funds can support the estimation of the true prevalence and incidence of CHC. In this article, the results of annual and quarterly analyses of prevalence and incidence for the years 2007-2013 are presented using data of several German sickness funds. Overall, the prevalence rate remained relatively stable at 0.2%, which is lower than the general assumption for Germany of 0.3%."

According to the news editors, the research concluded: "We found that despite the introduction of the breakthrough designated triple therapies with telaprevir or boceprevir in 2011, there was no increase of prevalence or incidence between 2010 and 2011."

For more information on this research see: The number of patients with chronic hepatitis C in times of new therapy options: a retrospective observational study on German health insurance funds data. European Journal of Gastroenterology & Hepatology, 2017;():. (Lippincott Williams and Wilkins - www.lww.com; European Journal of Gastroenterology & Hepatology - journals.lww.com/eurojgh/pages/default.aspx)

The news editors report that additional information may be obtained by contacting S. Thonnes, aTeam Gesundheit GmbH, EssenbAbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany. Additional authors for this research include H. Friedel and H. Frohlich.

Keywords for this news article include: Europe, Germany, Therapy, Wiesbaden, Epidemiology, Gastroenterology, Health Insurance, Clinical Research, Chronic Hepatitis C Virus, Clinical Trials and Studies, Liver Diseases and Conditions, Infectious Diseases and Conditions, Digestive System Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC